PeriPharm
PeriPharm is a privately held Montréal-based consulting firm founded in 2003 that provides pharmacoeconomics, health outcomes research, and market access services to healthcare innovators, operating with a small team of 11-50 employees.
- Company typePrivate
- Founded2003
- HeadquartersMontréal, Canada
- Headcount11–50
- GTM typeB2B
- OfferingServices
What PeriPharm does
PeriPharm is a privately held, Montréal-based consulting firm founded in 2003 that delivers pharmacoeconomics, health outcomes research, and market access services to companies developing healthcare innovations. The firm operates with a small team of 11-50 employees and presents itself as a specialist provider in the health economics and outcomes research (HEOR) domain, addressing the reimbursement, payer, and evidence-generation needs of pharma, biotech, and medical device innovators rather than running a generalist consulting practice.
The firm's core offering centers on analytical and advisory work tied to market access and reimbursement strategy. This typically encompasses health technology assessment (HTA) submissions, cost-effectiveness and budget-impact modeling, real-world evidence synthesis, and payer value communications for innovative therapies and devices. The underlying "product" is therefore expert analytical labor and codified methodology rather than a software platform; no proprietary technology stack, AI/ML components, or productized tooling are disclosed in the source data. There are no patents, trademarks, certifications, app assets, or API/SDK products referenced, consistent with a pure-services delivery model.
Commercially, PeriPharm operates as a fee-for-service professional services firm, with project-based engagements and likely retainer relationships with sponsors preparing for market entry, HTA review, or post-launch evidence generation. No pricing model, contract values, customer logos, distribution channels, or partnership arrangements are disclosed, and the company website returned only a loading/verification page rather than substantive content. The firm has no disclosed funding rounds, M&A activity, or strategic transactions, consistent with a bootstrapped, owner-operated professional services model that has sustained itself organically since founding.
PeriPharm firmographics
Firmographics- Name
- PeriPharm
- Website
- https://peripharm.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- PeriPharm is a privately held Montréal-based consulting firm founded in 2003 that provides pharmacoeconomics, health outcomes research, and market access services to healthcare innovators, operating with a small team of 11-50 employees.
- Ownership category
- akta.pro rank
PeriPharm industry classification
Industry- Product category
- Pharmacoeconomic & Market Access Consulting
- NAICS
- Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
- akta.pro primary industry
- Pharmacy Benefit Analytics, Reporting & Employer Consulting (HLAEAKAK)
- akta.pro secondary industry
- Formulary Management & Clinical Pharmacy Programs (HLAEAKAA)
Keywords
Where PeriPharm is headquartered
LocationHeadquarters
- HQ city
- Montréal
- HQ country
- Canada
- HQ region
- North America
Markets served
PeriPharm business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
PeriPharm product offering
Product offeringCore offering
PeriPharm provides pharmacoeconomics, health outcomes research, and market access consulting services for healthcare innovations. The firm supports pharmaceutical and healthcare organizations in demonstrating the economic and clinical value of their products and navigating access to reimbursement and formulary decisions.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmacoeconomics Consulting Economic evaluation of pharmaceuticals and healthcare interventions, including cost-effectiveness analysis, budget impact modeling, and pricing studies for pharma, biotech, and medical device clients.
- Health Outcomes Research Real-world evidence and outcomes research services to support clinical and economic value demonstration of healthcare innovations for payer and HTA submissions.
- Market Access Consulting Strategy and evidence support to help healthcare innovators achieve reimbursement, formulary listing, and successful uptake of new products in target markets.
Companies that use PeriPharm
Customer profileIdeal customer profiles1 record
PeriPharm technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
PeriPharm competitors and assessment
Company assessmentBroad incumbents
- IQVIA: Global CRO and life sciences data platform with a large HEOR, real-world evidence, and market access consulting practice. Competes with PeriPharm for pharma HEOR and market access mandates, but at much larger scale across the full clinical-commercial lifecycle.
- ICON plc: Global CRO with a dedicated commercial and outcomes services arm offering HEOR, market access, and pricing/reimbursement consulting. Comparable to PeriPharm on outcomes research and market access, but with a much broader portfolio spanning clinical to commercial.
- Charles River Associates (CRA) Life Sciences Practice: Economic and strategy consulting firm with a life sciences practice covering HEOR, market access, and pricing. Comparable to PeriPharm on HEOR and market access work, but as part of a broader management consulting platform.
Emerging players
- Wickenstones: Boutique market access and pricing consultancy for pharma and biotech. Similar in scale and value proposition to PeriPharm, with overlapping focus on pricing, reimbursement, and value communications.
Direct peers
- Trinity Partners: Life sciences consulting firm with strong focus on market access, pricing, and commercial strategy for biopharma. Comparable to PeriPharm on market access and value demonstration work, with a similar boutique, senior-staffed model.
- Analysource (now Putnam Associates / Inizio Advisory): Market access, pricing, and HEOR consulting business serving pharma and biotech. Directly comparable to PeriPharm's market access and pharmacoeconomics offerings, with similar boutique-to-mid-size positioning.
- Analysis Group: Economic and financial consulting firm with a large health economics and outcomes research practice. Directly competes with PeriPharm on pharmacoeconomics and health outcomes research engagements for pharma, biotech, and medical device clients.
- Evidera (PPD/Thermo Fisher): Dedicated HEOR, market access, and real-world evidence consulting business now part of Thermo Fisher's PPD. Directly competes with PeriPharm on pharmacoeconomics, evidence synthesis, and payer engagement services for pharma and biotech clients.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat3 records
Key risks4 records
Key highlights4 records
Customer concentration
PeriPharm social profiles
Digital presencePeriPharm financial estimates
Financial estimateRevenue estimate
Valuation estimate
PeriPharm leadership team
Management profileNumber of profiles
PeriPharm funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PeriPharm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PeriPharm
What does PeriPharm do?
PeriPharm provides pharmacoeconomics, health outcomes research, and market access consulting services for healthcare innovations. The firm supports pharmaceutical and healthcare organizations in demonstrating the economic and clinical value of their products and navigating access to reimbursement and formulary decisions.
Is PeriPharm a public or private company?
PeriPharm is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was PeriPharm founded?
PeriPharm was founded in 2003. It employs 11 to 50 people.
Where is PeriPharm based?
PeriPharm is headquartered in Montréal, Canada, in the North America region.
Who are PeriPharm's main competitors?
Broad incumbents on record are IQVIA, ICON plc and Charles River Associates (CRA) Life Sciences Practice. Wickenstones is listed as an emerging player. Direct peers are Trinity Partners, Analysource (now Putnam Associates / Inizio Advisory), Analysis Group and Evidera (PPD/Thermo Fisher).
Does PeriPharm have an API?
No public API is recorded for PeriPharm.
What industry is PeriPharm in?
PeriPharm's product category is Pharmacoeconomic & Market Access Consulting. Its primary akta.pro industry code is HLAEAKAK, Pharmacy Benefit Analytics, Reporting & Employer Consulting, with a secondary code of HLAEAKAA, Formulary Management & Clinical Pharmacy Programs. Its NAICS code is 524292.